RNAi Makes Strides in Mammalian Functional Genomics

©2004 Nature Publishing GroupGenomic RNA interference (RNAi) libraries have proven valuable resources for scientists who study Drosophila and Caenorhabditis elegans. Mammalian libraries, though, have lagged behind. No longer: Teams at Cold Spring Harbor Laboratories (CSHL)1 in New York and the Netherlands Cancer Institute (NCI)2 in Amsterdam have separately created human libraries that target between 8,000 and 9,000 genes.While both sites used state-of-the-art technology, knowledge about RN

Written byAileen Constans
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

©2004 Nature Publishing Group

Genomic RNA interference (RNAi) libraries have proven valuable resources for scientists who study Drosophila and Caenorhabditis elegans. Mammalian libraries, though, have lagged behind. No longer: Teams at Cold Spring Harbor Laboratories (CSHL)1 in New York and the Netherlands Cancer Institute (NCI)2 in Amsterdam have separately created human libraries that target between 8,000 and 9,000 genes.

While both sites used state-of-the-art technology, knowledge about RNAi has grown so rapidly that both CSHL team leader Gregory Hannon and NCI team leader Rene Bernards say they are developing new RNAi libraries using the latest tools and techniques. "Having done perhaps half to a third of all human genes, we've learned so much about the science of RNAi in the last year that we're going back and doing it again now on both human and mouse, with vectors and approaches that incorporate the new science," Hannon says.

Meanwhile, the present ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies